The number of tumor cells in the peritoneal fluid of mice treated with GSK484 was reduced compared to mice treated with saline solution, and ascites occurring at an advanced stage of disease was also reduced in mice treated with the PAD4 inhibitor. Here, PADI4 is linked to neoplasm.